In addition, the high-expression group had a higher estimate score (Figure 4C), immune score (Figure 4D), stromal score (Figure 4E), and lower tumor purity (Figure 4F) (ALL p < 0.05), which indicate that FBLN5 has a significant effect on the immune status of the tumor microenvironment. This evidence concerns the gene FBLN5 and neoplasm.